Supplement use during an intergroup clinical trial for breast cancer (S0221)

The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during tre...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Zirpoli, Gary R., Brennan, Patrick M., Hong, Chi-Chen, McCann, Susan E., Ciupak, Gregory, Davis, Warren, Unger, Joseph M., Thomas Budd, G., Hershman, Dawn L., Moore, Halle C.F., Stewart, James, Isaacs, Claudine, Hobday, Timothy, Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Ambrosone, Christine B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2013
Onderwerpen:
Epidemiology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3552360/
https://ncbi.nlm.nih.gov/pubmed/23306462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2400-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items